Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03995017
Title Rucaparib Plus Ramucirumab With or Without Nivolumab in Advanced Gastric and Esophageal Adenocarcinoma (RiME)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Anwaar Saeed

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma


Ramucirumab + Rucaparib

Nivolumab + Ramucirumab + Rucaparib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.